Menopause drug fezolinetant safely reduces hot flushes for almost 6 months, reveals research
Fezolinetant reduces the frequency and severity of hot flushes during menopause for 24 weeks, without serious side effects, according to research presented at the 26th European Congress of Endocrinology in Stockholm. These findings provide further evidence …